nach oben

Erschienen in:

27.06.2018 | Review

Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis

verfasst von: Jucilene Freitas dos Santos, Cibelle de Melo Bastos Cavalcante, Fabiano Timbó Barbosa, Daniel Leite Góes Gitaí, Marcelo Duzzioni, Cristiane Queixa Tilelli, Ashok K. Shetty, Olagide Wagner de Castro

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

Crack cocaine consumption is one of the main public health challenges with a growing number of children intoxicated by crack cocaine during the gestational period. The primary goal is to evaluate the accumulating findings and to provide an updated perspective on this field of research.

Methods

Meta-analyses were performed using the random effects model, odds ratio (OR) for categorical variables and mean difference for continuous variables. Statistical heterogeneity was assessed using the I-squared statistic and risk of bias was assessed using the Newcastle–Ottawa Quality Assessment Scale. Ten studies met eligibility criteria and were used for data extraction.

Results

The crack cocaine use during pregnancy was associated with significantly higher odds of preterm delivery [odds ratio (OR), 2.22; 95% confidence interval (CI), 1.59–3.10], placental displacement (OR, 2.03; 95% CI 1.66–2.48), reduced head circumference (− 1.65 cm; 95% CI − 3.12 to − 0.19), small for gestational age (SGA) (OR, 4.00; 95% CI 1.74–9.18) and low birth weight (LBW) (OR, 2.80; 95% CI 2.39–3.27).

Conclusion

This analysis provides clear evidence that crack cocaine contributes to adverse perinatal outcomes. The exposure of maternal or prenatal crack cocaine is pointedly linked to LBW, preterm delivery, placental displacement and smaller head circumference.

Garcia RCT, Dati LMM, Fukuda S et al (2012) Neurotoxicity of anhydroecgonine methyl ester, a crack cocaine pyrolysis product. Toxicol Sci 128:223–234PubMedCrossRef

Hatsukami DK, Fischman MW (1996) Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA 276:1580–1588PubMedCrossRef

Ribeiro M, Dunn J, Sesso R et al (2006) Causes of death among crack cocaine users. Rev Bras Psiquiatr 28:196–202PubMedCrossRef

Narvaez JCM, Jansen K, Pinheiro RT et al (2014) Violent and sexual behaviors and lifetime use of crack cocaine: a population-based study in Brazil. Soc Psychiatry Psychiatr Epidemiol 49:1249–1255PubMedCrossRef

Friedman AS, Glassman K, Terras BA (2001) Violent behavior as related to use of marijuana and other drugs. J Addict Dis 20:49–72PubMedCrossRef

Riezzo I, Fiore C, De Carlo D et al (2012) Side effects of cocaine abuse: multiorgan toxicity and pathological consequences. Curr Med Chem 19:5624–5646PubMedCrossRef

Duailibi LB, Ribeiro M, Laranjeira R (2008) Profile of cocaine and crack users in Brazil. Cad Saude Publ 24:s545–s557CrossRef

Bell GL, Lau K (1995) Perinatal and neonatal issues of substance abuse. Pediatr Clin North Am 42:261–281PubMedCrossRef

Ganapathy V (2011) Drugs of abuse and human placenta. Life Sci 88:926–930PubMedCrossRef

10.

Richardson GA, Goldschmidt L, Larkby C (2007) Effects of prenatal cocaine exposure on growth: a longitudinal analysis. Pediatrics 120:e1017–e1027PubMedCrossRef

11.

Aghamohammadi A, Zafari M (2016) Crack abuse during pregnancy: maternal, fetal and neonatal complication. J Matern Fetal Neonatal Med 29:795–797PubMedCrossRef

12.

Burkett G, Bandstra ES, Cohen J et al (1990) Cocaine-related maternal death. Am J Obstet Gynecol 163:40–41PubMedCrossRef

13.

Dow-Edwards D (2010) Sex differences in the effects of cocaine abuse across the life span. Physiol Behav 100(3):208–215PubMedPubMedCentralCrossRef

14.

Legido A, Clancy RR, Spitzer AR, Finnegan LP (1992) Electroencephalographic and behavioral-state studies in infants of cocaine-addicted mothers. Am J Dis Child 146:748–752PubMed

15.

Kessler F, Pechansky F (2008) A psychiatric view on the crack phenomenon nowadays. RevKesslerista Psiquiatr do Rio Gd do Sul 30:96–98CrossRef

16.

Volpe JJ (1992) Effect of cocaine use on the fetus. N Engl J Med 327:399–407PubMedCrossRef

17.

Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341PubMedCrossRef

18.

Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies. J Am Med Assoc 283:2008–2012CrossRef

19.

Wells G, Shea B, O’Connell D, et al The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 27 Jun 2017

20.

Wu QJ, Yang Y, Vogtmann E et al (2013) Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Ann Oncol 24:1079–1087PubMedCrossRef

21.

Addis A, Moretti ME, Ahmed Syed F et al (2001) Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 15:341–369PubMedCrossRef

22.

De Castro AP, Cristina M, Guilam R et al (2013) Violência na velhice: abordagens em periódicos nacionais indexados Violence in old age: the issue addressed in indexed national journals. Ciência e Saúde Coletiva 18:1283–1292CrossRef

23.

Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B (2001) Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 285:1613–1625PubMedPubMedCentralCrossRef

24.

Gouin K, Murphy K, Shah PS (2011) Effects of cocaine use during pregnancy on low birthweight and preterm birth: Systematic review and metaanalyses. Am J Obstet Gynecol 204:340.e1–340.e12CrossRef

25.

Kosofsky BE, Wilkins AS, Gressens P, Evrard P (1994) Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities. J Child Neurol 9:234–241PubMedCrossRef

26.

McCarthy DM, Kabir ZD, Bhide PG, Kosofsky BE (2014) Effects of prenatal exposure to cocaine on brain structure and function. Prog Brain Res 211:277–289PubMedCrossRef

27.

Fajemirokun-Odudeyi O, Lindow SW (2004) Obstetric implications of cocaine use in pregnancy: a literature review. Eur J Obstet Gynecol Reprod Biol 112:2–8PubMedCrossRef

28.

Burns K, Chethik L, Burns WJ, Clark R (1991) Dyadic disturbances in cocaine???abusing mothers and their infants. J Clin Psychol 47:316–319PubMedCrossRef

29.

Eiden RD, Stevens A, Schuetze P, Dombkowski LE (2006) Conceptual model for maternal behavior among polydrug cocaine-using mothers: the role of postnatal cocaine use and maternal depression. Psychol Addict Behav 20:1–10PubMedPubMedCentralCrossRef

30.

Tronick EZ, Messinger DS, Weinberg MK et al (2005) Cocaine exposure is associated with subtle compromises of infants’ and mothers’ social-emotional behavior and dyadic features of their interaction in the face-to-face still-face paradigm. Dev Psychol 41:711–722PubMedCrossRef

31.

Black M, Nair P, Kight C et al (1994) Parenting and early development among children of drug abusing women: effects of home intervention. Pediatrics 94(4 Pt 1):440–448PubMed

32.

Minnes S, Singer L, Min MO et al (2014) Effects of prenatal cocaine/polydrug exposure on substance use by age 15. Drug Alcohol Depend 134:201–210PubMedCrossRef

33.

Minnes S, Singer LT, Arendt R, Satayathum S (2005) Effects of prenatal cocaine/polydrug use on maternal-infant feeding interactions during the first year of life. Nat Rev Mol Cell Biol 26:194–200

34.

Garland OH (1895) Fatal acute poisoning by cocaine. Lancet 146:1104–1105CrossRef

35.

Almond D, Chay K, Lee D (2005) The Costs of Low Birth Weight. Q J Econ 120:1031–1083

36.

Barker DJ (1995) Fetal origins of coronary heart disease. BMJ Br Med J 311:171CrossRef

37.

Black SE, Devereux JP, Salvanes KG (2007) From the cradle to the labor market? the effect of birth weight on adult outcomes. Q J Econ 122(1):409–439CrossRef

38.

Schulz LC (2010) The Dutch hunger winter and the developmental origins of health and disease. Proc Natl Acad Sci 107:16757–16758PubMedCrossRef

39.

Mazumder B, Almond D (2011) Health capital and the prenatal environment: the effect of maternal fasting during pregnancy. FRB of Chicago Working Paper No. 2007–22 1–74

40.

de Rooij SR, Wouters H, Yonker JE et al (2010) Prenatal undernutrition and cognitive function in late adulthood. Proc Natl Acad Sci 107:16881–16886PubMedCrossRef

41.

Stein Z, Susser M, Saenger G, Marolla F (1975) Famine and human development: the Dutch hunger winter of 1944–1945. Oxford University Press, New York, NY, US, pp 1–284

42.

Singer LT, Nelson S, Short E et al (2008) Prenatal cocaine exposure: drug and environmental effects at 9 years. J Pediatr 153:105–111PubMedPubMedCentralCrossRef

43.

Thompson BL, Levitt P, Stanwood GD (2009) Prenatal exposure to drugs: effects on brain development and implications for policy and education. 2 Nat Rev Neurosci 10:303–312CrossRef

44.

Minnes S, Singer LT, Kirchner HL et al (2010) The effects of prenatal cocaine exposure on problem behavior in children 4-10 years. Neurotoxicol Teratol 32:443–451PubMedPubMedCentralCrossRef

45.

Minnes S, Min M, Wu M et al (2014) Executive function in adolescents with prenatal exposure to cocaine. Neurotoxicol Teratol 43:84CrossRef

46.

Greenwald MK, Chiodo LM, Hannigan JH et al (2011) Teens with heavy prenatal cocaine exposure respond to experimental social provocation with escape not aggression. Neurotoxicol Teratol 33:198–204PubMedCrossRef

47.

Richardson GA, Larkby C, Goldschmidt L, Day NL (2013) Adolescent initiation of drug use: effects of prenatal cocaine exposure. J Am Acad Child Adolesc Psychiatry 52:37–46PubMedCrossRef

48.

Goldenberg RL, Culhane JF, Iams JD, Romero R (2009) Preterm birth 1: epidemiology and causes of preterm birth. Obstet Anesth Dig 29:6–7CrossRef

49.

Purisch SE, Gyamfi-Bannerman C (2017) Epidemiology of preterm birth. Semin Perinatol 41(7):387–391PubMedCrossRef

50.

Rees S, Inder T (2005) Fetal and neonatal origins of altered brain development. Early Hum Dev 81:753–761PubMedCrossRef

51.

Jobe AH, Bancalari E (2001) NICHD/NHLBI/ORD workshop summary. Am J Respir Crit Care Med 163:1723–1729PubMedCrossRef

52.

Saigal S, Doyle LW (2008) [Commentary on] The lancet series on preterm birth (3): an overview of mortality and sequelae of preterm birth from infancy to adulthood. Child Care Heal Dev 34:407–408

53.

Doyle LW, Saigal S (2009) Long-term outcomes of very preterm or tiny infants. Neoreviews 10:e130–e137CrossRef

54.

Morgan MA, Honnebier MBOM, Mecenas C, Nathanielsz PW (1996) Cocaine’s effect on plasma oxytocin concentrations in the baboon during late pregnancy. Am J Obstet Gynecol 174:1026–1027PubMedCrossRef

55.

Williams SK, Johns JM (2014) Prenatal and gestational cocaine exposure: effects on the oxytocin system and social behavior with implications for addiction. Pharmacol Biochem Behav 119:10–21PubMedCrossRef

56.

Petitti DB, Coleman C (1990) Cocaine and the risk of low birth weight. Am Public Heal Assoc 80:25–28CrossRef

57.

Glatt SJ, Bolanos CA, Trksak GH et al (2000) Prenatal cocaine exposure alters behavioral and neurochemical sensitization to amphetamine in adult rats. Neuropharmacology 39:599–610PubMedCrossRef

58.

Chae S-M, Covington CY (2009) Biobehavioral outcomes in adolescents and young adults prenatally exposed to cocaine: evidence from animal models. Biol Res Nurs 10:318–330PubMedCrossRef

59.

Buckingham-Howes S, Berger SS, Scaletti LA, Black MM (2013) Systematic review of prenatal cocaine exposure and adolescent development. Pediatrics 131:e1917–e1936PubMedPubMedCentralCrossRef

60.

Behnke M, Smith VC (2013) Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics 131:e1009–e1024PubMedCrossRef

61.

Overstreet DH, Moy SS, Lubin DA et al (2000) Enduring effects of prenatal cocaine administration on emotional behavior in rats. Physiol Behav 70:149–156PubMedPubMedCentralCrossRef

62.

Liu J, Lester BM (2011) Reconceptualizing in a dual-system model the effects of prenatal cocaine exposure on adolescent development: a short review. Int J Dev Neurosci 29:803–809PubMedCrossRef

63.

Lambert BL, Bauer CR (2012) Developmental and behavioral consequences of prenatal cocaine exposure: a review. J Perinatol 32:819–828PubMedPubMedCentralCrossRef

64.

Henderson JJ, McWilliam OA, Newnham JP, Pennell CE (2012) Preterm birth aetiology 2004-2008. Maternal factors associated with three phenotypes: spontaneous preterm labour, preterm pre-labour rupture of membranes and medically indicated preterm birth. J Matern Fetal Neonatal Med 25:642–647PubMedCrossRef

65.

Smith LK, Draper ES, Manktelow BN et al (2007) Socioeconomic inequalities in very preterm birth rates. Arch Dis Child Fetal Neonatal Ed 92:F11–F14PubMedCrossRef

66.

Ion R, Bernal AL (2015) Smoking and preterm birth. Reprod Sci 22:918–926PubMedCrossRef

67.

Nordstrom-Klee B, Delaney-Black V, Covington C et al (2002) Growth from birth onwards of children prenatally exposed to drugs: a literature review. Neurotoxicol Teratol 24:481–488PubMedCrossRef

68.

Treit S, Zhou D, Chudley AE et al (2016) Relationships between head circumference, brain volume and cognition in children with prenatal alcohol exposure. PLoS One 11:1–15CrossRef

69.

Rollins JD, Collins JS, Holden KR (2010) United States head circumference growth reference charts: birth to 21 years. J Pediatr 156(6):907–913.e2PubMedCrossRef

70.

Gale CR, Walton S, Martyn CN (2003) Foetal and postnatal head growth and risk of cognitive decline in old age. Brain Epub 126(Pt 10):2273–2278CrossRef

71.

Gale CR, O’Callaghan FJ, Godfrey KM et al (2004) Critical periods of brain growth and cognitive function in children. Brain 127:321–329PubMedCrossRef

72.

Gale CR, O’Callaghan FJ, Bredow M, Martyn CN (2006) The influence of head growth in fetal life, infancy, and childhood on intelligence at the ages of 4 and 8 years. Pediatrics 118:1486–1492PubMedCrossRef

73.

Bray PF, Shields WD, Wolcott GJ, Madsen JA (1968) Occipitofrontal head circumference—an accurate measure of intracranial volume. J Pediatr 75:3–5

74.

Bartholomeusz HH, Courchesne E, Karns CM (2002) Relationship between head circumference and brain volume in healthy normal toddlers, children, and adults. Neuropediatrics 33:232–238CrossRef

75.

Holden K, Lyons M (2009) Acquired microcephaly. In: Maria BL E (ed) Current management in child neurology, 4th ed. Canada

76.

Williams CA, Dagli A, Battaglia A (2008) Genetic disorders associated with macrocephaly. Am J Med Genet Part A 146:2023–2037CrossRef

77.

He N, Lidow MS (2004) Cerebral cortical abnormalities seen in a non-human primate model of prenatal cocaine exposure are not related to vasoconstriction. Neurotoxicology 25:419–432PubMedCrossRef

78.

Jones L, Fischer I, Levitt P (1996) Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cereb Cortex 6:431–445PubMedCrossRef

79.

Lidow MS, Song ZM (2001) Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J Comp Neurol 435:263–275PubMedCrossRef

80.

Lidow MS, Song ZM (2001) Effect of cocaine on cell proliferation in the cerebral wall of monkey fetuses. Cereb Cortex 11:545–551PubMedCrossRef

81.

Baraban SC, Wenzel HJ, Castro PA, Schwartzkroin PA (1999) Hippocampal dysplasia in rats exposed to cocaine in utero. Dev Brain Res 117:213–217CrossRef

82.

Mcmurray MS, Oguz I, Rumple AM et al (2015) Effects of prenatal cocaine exposure on early postnatal rodent brain structure and diffusion properties. Neurotoxicol Teratol 47:80–88PubMedCrossRef

83.

Wiggins RC, Ruiz B (1990) Development under the influence of cocaine. II. Comparison of the effects of maternal cocaine and associated undernutrition on brain myelin development in the offspring. Metab Brain Dis 5:101–109PubMedCrossRef

84.

Bateman DA, Chiriboga CA (2000) Dose-response effect of cocaine on newborn head circumference. Pediatrics 106:E33PubMedCrossRef

85.

Areal LB, Rodrigues LCM, Andrich F et al (2015) Behavioural, biochemical and molecular changes induced by chronic crack-cocaine inhalation in mice: the role of dopaminergic and endocannabinoid systems in the prefrontal cortex. Behav Brain Res 290:8–16PubMedCrossRef

86.

Sakornbut E, Leeman L, Fontaine P (2007) 5—Late pregnancy bleeding. Am Fam Physician 75:1199–1206PubMed

87.

Fiori O, Verstraete L, Berkane N (2007) Risk factors of abruptio placentae among Peruvian women. Am J Obstet Gynecol 196:e15PubMedCrossRef

88.

Ananth CV, Getahun D, Peltier MR, Smulian JC (2006) Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. Obstet Gynecol 107:785–792PubMedCrossRef

89.

Ananth CV, Smulian JC, Demissie K et al (2001) Placental abruption among singleton and twin births in the United States: risk factor profiles. Am J Epidemiol 153:771–778PubMedCrossRef

90.

Ananth CV, Savitz DA, Williams MA (1996) Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and meta-analysis. Obstet Gynecol 88:309–318PubMedCrossRef

91.

Ananth CV, Savitz DA, Luther ER (1996) Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol 144:881–889PubMedCrossRef

92.

Ananth CV, Savitz DA, Bowes WA, Luther ER (1997) Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy. Br J Obstet Gynaecol 104:572–578PubMedCrossRef

93.

Ananth CV, Oyelese Y, Srinivas N et al (2004) Preterm premature rupture of membranes, intrauterine infection, and oligohydramnios: risk factors for placental abruption. Obstet Gynecol 104:71–77PubMedCrossRef

94.

Sheiner E, Shoham-Vardi I, Hallak M et al (2003) Placental abruption in term pregnancies: clinical significance and obstetric risk factors. J Matern Fetal Neonatal Med 13:45–49PubMedCrossRef

95.

Salihu HM, Bekan B, Aliyu MH et al (2005) Perinatal mortality associated with abruptio placenta in singletons and multiples. Am J Obstet Gynecol 193:198–203PubMedCrossRef

96.

Bateman DA, Ng SK, Hansen CA, Heagarty MC (1993) The effects of intrauterine cocaine exposure in newborns. Rev Mal Respir 83:190–193

97.

Cherukuri R, Minkoff H, Feldman J et al (1988) A cohort study of alkaloidal cocaine (“crack”) in pregnancy. Obstet Gynecol 72:147–151PubMed

98.

Eyler FD, Behnke M, Conlon M et al (1994) Prenatal cocaine use: a comparison of neonates matched on maternal risk factors. Neurotoxicol Teratol 16:81–87PubMedCrossRef

99.

Sprauve ME, Lindsay MK, Herbert S, Graves W (1997) Adverse perinatal outcome in parturients who use crack cocaine. Obstet Gynecol 89:674–678PubMedCrossRef

100.

Aliyu MH, Lynch O, Wilson RE et al (2011) Association between tobacco use in pregnancy and placenta-associated syndromes: a population-based study. Arch Gynecol Obstet 283:729–734PubMedCrossRef

101.

Agarwal R, Gupta B, Radhakrishnan G (2011) Rupture of intrapartum unscarred uterus at the fundus: a complication of passive cocaine abuse? Arch Gynecol Obstet 283:53–54PubMedCrossRef

102.

Wu L, Yan J, Qu SC et al (2012) Abnormal regulation for progesterone production in placenta with prenatal cocaine exposure in rats. Placenta 33:977–981PubMedCrossRef

103.

Lockwood CJ, Krikun G, Papp C et al (1994) The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation. Ann N Y Acad Sci 734:57–79PubMedCrossRef

104.

Moore KL (1988) Formation of the bilaminar embryo. In: Wonsiewicz M (ed) The developing human: clinically oriented embryology, vol 4. W.B. Saunders, Philadelphia, pp 38–49

105.

Pritchard JA, Wright MR (1959) Pathogenesis of hypofibrinogenemia in placental abruption. N Engl J Med 261:218–222PubMedCrossRef

106.

Chasnoff IJ, Lewis DE, Griffith DR, Willey S (1989) Cocaine and pregnancy: clinical and toxicological implications for the neonate. Clin Chem 35:1276–1278PubMed

107.

Behnke M, Eyler FD, Garvan CW, Wobie K (2001) The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics 107:E74PubMedCrossRef

108.

Garcia RCT, Torres LH, Balestrin NT et al (2017) Anhydroecgonine methyl ester, a cocaine pyrolysis product, may contribute to cocaine behavioral sensitization. Toxicology 376:44–50PubMedCrossRef

109.

Jacob P, Jones RT, Benowitz NL et al (1990) Cocaine smokers excrete a pyrolysis product, anhydroecgonine methyl ester. J Toxicol Clin Toxicol 28:121–125PubMedCrossRef

110.

Kintz P, Cirimele V, Sengler C, Mangin P (1995) Testing human hair and urine for anhydroecgonine methyl ester, a pyrolysis product of cocaine. J Anal Toxicol 19:479–482PubMedCrossRef

111.

Martin BR, Lue LP, Boni JP (1989) Pyrolysis and volatilization of cocaine. J Anal Toxicol 13:158–162PubMedCrossRef

112.

Toennes SW, Fandiño AS, Hesse F-J, Kauert GF (2003) Artifact production in the assay of anhydroecgonine methyl ester in serum using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 792:345–351PubMedCrossRef

113.

Toennes SW, Fandiño AS, Kauert G (1999) Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crack. J Chromatogr B Biomed Sci Appl 735:127–132PubMedCrossRef

114.

Gomes EF, Lipaus IFS, Martins CW et al (2017) Anhydroecgonine methyl ester (AEME), a product of cocaine pyrolysis. Impairs Spatial Working Memory and Induces Striatal Oxidative Stress in Rats, Neurotox Res

115.

UNODC (2016) United Nations office on drugs and crime. In: Report WD (ed) UN office on drugs and crime. World Drug Report, Vienna

116.

Miguel AQC, Madruga CS, Cogo-Moreira H et al (2016) Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: a randomized controlled trial. Psychol Addict Behav 30:536–543PubMedPubMedCentralCrossRef

117.

Des Jarlais DC, McKnight C, Arasteh K et al (2014) A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York city. Subst Use Misuse 49:783–792PubMedPubMedCentralCrossRef

118.

DeBeck K, Buxton J, Kerr T et al (2011) Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder. Subst Abuse Treat Prev Policy 6:4PubMedPubMedCentralCrossRef

119.

Sterk CE, Elifson KW, DePadilla L (2014) Neighbourhood structural characteristics and crack cocaine use: exploring the impact of perceived neighbourhood disorder on use among African Americans. Int J Drug Policy 25:616–623PubMedCrossRef

120.

Parker MA, Anthony JC (2014) Should anyone be riding to glory on the now-descending limb of the crack-cocaine epidemic curve in the United States? Drug Alcohol Depend 138:225–228PubMedPubMedCentralCrossRef

121.

Werb D, Debeck K, Kerr T et al (2010) Modelling crack cocaine use trends over 10 years in a Canadian setting. Drug Alcohol Rev 29:271–277PubMedPubMedCentralCrossRef

122.

Moreira MM, Barbosa GL, Laranjeira R, Mitsuhiro SS (2014) Alcohol and Crack cocaine use in women: a 14-year cross-sectional study. J Addict Dis 33:9–14PubMedCrossRef

123.

Parcianello RR, Mardini V, Ceresér KMM et al (2018) Increased cocaine and amphetamine-regulated transcript cord blood levels in the newborns exposed to crack cocaine in utero. Psychopharmacol 235(1):215–222CrossRef

124.

Mardini V, Rohde LA, Ceresér KM et al (2017) TBARS and BDNF levels in newborns exposed to crack/cocaine during pregnancy: a comparative study. Rev Bras Psiquiatr 39:263–266PubMedCrossRef

125.

Jones W (2015) Cocaine use and the breastfeeding mother. Pract Midwife 18:19–22PubMed

126.

Morrow CE, Culbertson JL, Accornero VH et al (2006) Learning disabilities and intellectual functioning in school-aged children with prenatal cocaine exposure. Dev Neuropsychol 30:905–931PubMedPubMedCentralCrossRef

127.

Bandstra ES, Vogel AL, Morrow CE et al (2004) Severity of prenatal cocaine exposure and child language functioning through age 7 years: a longitudinal latent growth curve analysis. Subst Use Misuse 39:25–59PubMedPubMedCentralCrossRef

128.

Warner TD, Behnke M, Hou W et al (2006) Predicting caregiver-reported behavior problems in cocaine-exposed children at 3 years. J Dev Behav Pediatr 27:83–92PubMedPubMedCentralCrossRef

129.

Hess ARB, Menezes CB, de Almeida RMM (2018) Inhibitory control and impulsivity levels in women crack users. Subst Use Misuse 53(6):972–979PubMedCrossRef

130.

Levandowski ML, Hess ARB, Grassi-Oliveira R, de Almeida RMM (2016) Plasma interleukin-6 and executive function in crack cocaine-dependent women. Neurosci Lett 628:85–90PubMedCrossRef

131.

Duff P, Tyndall M, Buxton J et al (2013) Sex-for-crack exchanges: associations with risky sexual and drug use niches in an urban Canadian city. Harm Reduct J 10:29PubMedPubMedCentralCrossRef

132.

Vernaglia TVC, Vieira RA de MS, Cruz MS (2015) Crack cocaine users living on the streets – gender characteristics. Cien Saude Colet 20:1851–1859

133.

Kopetz CE, Collado A, Lejuez CW (2015) When the end (automatically) justifies the means: automatic tendency toward sex exchange for crack cocaine. Motiv Sci 1:233–244PubMedPubMedCentralCrossRef

134.

Chouteau M, Namerow PB, Leppert P (1988) The effect of cocaine abuse on birth weight and gestational age. Obstet Gynecol 72(3 Pt 1):351–354PubMed

135.

Eyler FD, Behnke M, Conlon M et al (1998) Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth. Pediatrics 101:229–237PubMedCrossRef

136.

Richardson GA, Hamel SC, Goldschmidt L, Day NL (1999) Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample. Pediatrics 104:e18PubMedCrossRef

Titel: Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis
verfasst von: Jucilene Freitas dos Santos
Cibelle de Melo Bastos Cavalcante
Fabiano Timbó Barbosa
Daniel Leite Góes Gitaí
Marcelo Duzzioni
Cristiane Queixa Tilelli
Ashok K. Shetty
Olagide Wagner de Castro
Publikationsdatum: 27.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 3/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-018-4833-2

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis

Abstract

Objective

Methods

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Menopausale Hormontherapie für Frauen über 65?

Update Gynäkologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Tocolysis with the β2-sympathomimetic fenoterol does not increase the occurrence of infantile hemangioma in preterm and term infants

sFlt-1/PlGF ratio for the prediction of the time of delivery

Mode of delivery of triplet pregnancy: hidden factors that should be considered

The influence of seasonal variations on in vitro fertilization and fresh/frozen embryo transfer: a retrospective study

Efficient prevention of preterm birth as a primary political task—results of the Thuringia campaign 2017

GDF9-β promotes folliculogenesis in sheep ovarian transplantation onto the chick embryo chorioallantoic membrane (CAM) in cryopreservation programs

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Menopausale Hormontherapie für Frauen über 65?

Update Gynäkologie